Shire Plc American Depositary Shares (SHPG) 239.82 $SHPG
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 13, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), XON: 39.30 (+1.05), CTIC: 2.23 (-0.02), PFNX: 12.45 (+0.29), JNJ: 99.62 (+1.18), ANTM: 141.05 (-0.95), NVAX: 8.80 (+0.40), SHPG: 239.82 (+6.11), ABBV: 58.05 (+1.00), TBPH: 18.51 (+0.28), SNY: 49.42 (+0.82), ALQA: 6.14 (+0.09), REGN: 402.40 (+0.66), ONCY: 0.51 (+0.02), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), EPRS: 7.67 (+0.67), AMGN: 153.48 (+0.30), NKTR: 13.54 (-0.14), ZTS: 45.46 (-0.33), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), GERN: 3.03 (unch)
Today's Market: Earnings Moving These Stocks, M&A In Pharma And Big Management Shakeups
Matthew Smith - at Seeking Alpha - Fri Feb 13, 8:56AM CST
VRX: 167.00 (-0.50), CAG: 34.83 (-1.59), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17), NPSP: 45.88 (+0.03), KRFT: 64.42 (-1.75), AIG: 53.96 (+1.51), ZNGA: 2.24 (-0.42), KING: 16.70 (+1.96)
Shire Misses on Q4 Earnings, Revenues Beat; Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 8:54AM CST
Shire plc (SHPG) reported fourth-quarter 2014 earnings (excluding special items and amortization) of $2.63 per American Depositary Share (ADS), missed the Zacks Consensus Estimate of $2.66.
SHPG: 239.82 (+6.11), SCMP: 15.32 (+0.04), NPSP: 45.88 (+0.03), ABBV: 58.05 (+1.00)
Shire Plc (SHPG) Earnings Report: Q4 2014 Conference Call Transcript
at The Street - Fri Feb 13, 7:03AM CST
The following Shire Plc (SHPG) conference call took place on February 12, 2015, 09:00 AM ET. This is a transcript of that earnings call:
SHPG: 239.82 (+6.11)
Wall Street Breakfast: GDP Figures Lead Europe Higher
Wall Street Breakfast - at Seeking Alpha - Fri Feb 13, 5:31AM CST
VRX: 167.00 (-0.50), SPY: 209.78 (+0.86), QQQ: 106.91 (+0.91), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17), GM: 37.62 (-0.40), AIG: 53.96 (+1.51), ZNGA: 2.24 (-0.42), GRPN: 7.97 (+0.51), FSL: 37.53 (+2.83), MT: 11.20 (+0.74)
Shire now on the hunt for Salix
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 12:58AM CST
VRX: 167.00 (-0.50), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17)
Shire rises on NPS potential
at Investor's Business Daily - Thu Feb 12, 5:30PM CST
The Irish drugmaker reported a 19% jump in Q4 earnings to $2.63 per American depositary share, but fell short of views by 5 cents. Revenue climbed 19% to $1.58 bil, topping views. The results were overshadowed by excitement over the company's $5.2...
SHPG: 239.82 (+6.11), NPSP: 45.88 (+0.03)
Shire's (SHPG) CEO Flemming Ornskov on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 12, 4:44PM CST
SHPG: 239.82 (+6.11)
Alaska AG investigating Impax Labs over possible pay-to-delay deals
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 4:33PM CST
IPXL: 39.51 (+0.69), ENDP: 84.01 (+1.12), PFE: 34.64 (-0.23), SHPG: 239.82 (+6.11)
Shire Moves Up On NPS Potential; Q4 Earnings Miss
at Investor's Business Daily - Thu Feb 12, 9:45AM CST
Shares of Shire (SHPG) moved higher early Thursday as the Irish drugmaker's better-than-expected quarterly revenue and upbeat 2015 outlook offset an earnings miss. Reporting before the open, Shire logged fourth-quarter earnings of $2.63 per American...
AGN: 229.49 (+1.87), VRX: 167.00 (-0.50), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17), NPSP: 45.88 (+0.03), ABBV: 58.05 (+1.00)
Shire (SHPG) Highlighted As Momo Momentum Stock
at The Street - Thu Feb 12, 9:24AM CST
Trade-Ideas LLC identified Shire (SHPG) as a momo momentum candidate
SHPG: 239.82 (+6.11)
Shire Q4 CF Ops up big on receipt of $1.635B break-up fee from AbbVie
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 7:19AM CST
SHPG: 239.82 (+6.11)
Shire PLC misses by $0.04, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 6:41AM CST
SHPG: 239.82 (+6.11)
Shire Delivers Record Revenues and Non GAAP Earnings per ADS in 2014, and Enters 2015 With Strongest-Ever Pipeline
PR Newswire Europe - Thu Feb 12, 6:01AM CST
DUBLIN, Ireland, February 12, 2015 /PRNewswire/ --
SHPG: 239.82 (+6.11)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 4:30PM CST
NLSN: 45.59 (+2.02), RTIX: 5.54 (+0.19), AAP: 150.16 (-1.26), JAH: 51.18 (+0.18), LMNS: 10.80 (+0.57), THS: 80.00 (-1.57), RWLK: 17.40 (-0.77), CAB: 53.55 (+1.23), FAF: 37.00 (+0.10), HSP: 87.35 (unch), PNK: 25.64 (-0.35), MFA: 7.89 (unch), SPW: 87.37 (-2.81), MFC: 17.31 (+0.27), HIMX: 8.04 (+0.28), LNCE: 30.72 (-0.25), TIME: 24.84 (+0.35), AVP: 9.08 (+0.39), INCY: 75.94 (+0.28), NNN: 41.00 (+0.20), NWE: 53.61 (-0.85), COR: 48.08 (+1.08), MHFI: 102.19 (unch), NCI: 14.99 (-0.01), BWA: 60.17 (-1.21), HERO: 0.92 (+0.02), NRP: 7.86 (-0.45), STC: 37.85 (+0.23), AB: 27.17 (+0.47), CPLA: 65.23 (-1.37), TU: 34.83 (+0.01), IFF: 116.96 (+2.19), GNC: 48.11 (-0.55), MINI: 40.62 (-0.83), ACOR: 36.14 (-0.51), CVE: 19.42 (-0.29), SNI: 73.00 (+0.39), CCE: 43.69 (-0.66), K: 63.20 (-0.10), DPS: 76.95 (-1.35), BG: 82.22 (+1.78), AAWW: 48.01 (+0.44), Q: 63.31 (+0.06), SHPG: 239.82 (+6.11), MANU: 17.20 (-0.21), MPEL: 27.54 (+0.78), APA: 67.05 (+2.47), DBD: 35.82 (+1.07), MPW: 14.64 (+0.14), HE: 33.14 (-0.22), RYN: 28.02 (-1.15), CS: 23.65 (+0.23), PDS: 6.04 (+0.12), ANR: 1.27 (+0.03), SON: 46.65 (-0.79), SKYW: 13.84 (+1.88), LPNT: 69.04 (-0.06), RDN: 16.10 (-0.43), MDWD: 7.22 (+0.17), SCOR: 53.35 (-1.10), FLO: 21.68 (+0.38)
Greece Weighs On Stocks; TripAdvisor Up After Close
at Investor's Business Daily - Wed Feb 11, 3:57PM CST
Stocks ended mixed Wednesday as investors awaited the outcome of talks aimed at resolving Greece's debt crisis. The Nasdaq edged up 0.3%, while the S&P 500 ended flat and the Dow Jones industrial average dipped a fraction. Volume was also mixed,...
DPS: 76.95 (-1.35), WWAV: 38.65 (+0.61), WFM: 56.15 (-0.15), TSLA: 203.77 (+0.89), SSNC: 63.38 (+1.40), SHPG: 239.82 (+6.11), AMAT: 24.12 (-0.02), TRIP: 84.81 (+2.41), CSCO: 29.43 (-0.03)
Why Sangamo Biosciences Inc. Shares Rocketed Higher Today
Todd Campbell, The Motley Fool - Motley Fool - Wed Feb 11, 11:58AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Sangamo Biosciences shares surged more than 14%...
BIIB: 391.66 (-0.45), SHPG: 239.82 (+6.11), SGMO: 15.40 (+0.14)
Congratulations Covidien: You Escaped In Time
Chris DeMuth Jr. - Seeking Alpha - Wed Feb 11, 8:19AM CST
Originally published on February 4, 2015 The Shakedown In 2014, Obama vowed to punish tax inverting companies by any means necessary - inside and outside of legislation. He took scalps including Shire (NASDAQ: SHPG ) and Walgreens (NASDAQ: WBA...
VRX: 167.00 (-0.50), WBA: 78.73 (-1.23), MDT: 75.26 (+0.33), COV: 106.71 (-1.36), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17), NPSP: 45.88 (+0.03), ABBV: 58.05 (+1.00)
Will Sangamo (SGMO) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 12:10PM CST
Sangamo BioSciences, Inc. (SGMO) is scheduled to report fourth-quarter 2014 results on Feb 10, 2015 and holds a Zacks Rank #3 (Hold) with an Earnings ESP of 0.00%.
BIIB: 391.66 (-0.45), ACT: 285.37 (+3.71), SHPG: 239.82 (+6.11), SGMO: 15.40 (+0.14)
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 13, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), XON: 39.30 (+1.05), CTIC: 2.23 (-0.02), PFNX: 12.45 (+0.29), JNJ: 99.62 (+1.18), ANTM: 141.05 (-0.95), NVAX: 8.80 (+0.40), SHPG: 239.82 (+6.11), ABBV: 58.05 (+1.00), TBPH: 18.51 (+0.28), SNY: 49.42 (+0.82), ALQA: 6.14 (+0.09), REGN: 402.40 (+0.66), ONCY: 0.51 (+0.02), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), EPRS: 7.67 (+0.67), AMGN: 153.48 (+0.30), NKTR: 13.54 (-0.14), ZTS: 45.46 (-0.33), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), GERN: 3.03 (unch)
Today's Market: Earnings Moving These Stocks, M&A In Pharma And Big Management Shakeups
Matthew Smith - at Seeking Alpha - Fri Feb 13, 8:56AM CST
VRX: 167.00 (-0.50), CAG: 34.83 (-1.59), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17), NPSP: 45.88 (+0.03), KRFT: 64.42 (-1.75), AIG: 53.96 (+1.51), ZNGA: 2.24 (-0.42), KING: 16.70 (+1.96)
Shire Misses on Q4 Earnings, Revenues Beat; Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 8:54AM CST
Shire plc (SHPG) reported fourth-quarter 2014 earnings (excluding special items and amortization) of $2.63 per American Depositary Share (ADS), missed the Zacks Consensus Estimate of $2.66.
SHPG: 239.82 (+6.11), SCMP: 15.32 (+0.04), NPSP: 45.88 (+0.03), ABBV: 58.05 (+1.00)
Shire Plc (SHPG) Earnings Report: Q4 2014 Conference Call Transcript
at The Street - Fri Feb 13, 7:03AM CST
The following Shire Plc (SHPG) conference call took place on February 12, 2015, 09:00 AM ET. This is a transcript of that earnings call:
SHPG: 239.82 (+6.11)
Wall Street Breakfast: GDP Figures Lead Europe Higher
Wall Street Breakfast - at Seeking Alpha - Fri Feb 13, 5:31AM CST
VRX: 167.00 (-0.50), SPY: 209.78 (+0.86), QQQ: 106.91 (+0.91), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17), GM: 37.62 (-0.40), AIG: 53.96 (+1.51), ZNGA: 2.24 (-0.42), GRPN: 7.97 (+0.51), FSL: 37.53 (+2.83), MT: 11.20 (+0.74)
Shire now on the hunt for Salix
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 12:58AM CST
VRX: 167.00 (-0.50), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17)
Shire rises on NPS potential
at Investor's Business Daily - Thu Feb 12, 5:30PM CST
The Irish drugmaker reported a 19% jump in Q4 earnings to $2.63 per American depositary share, but fell short of views by 5 cents. Revenue climbed 19% to $1.58 bil, topping views. The results were overshadowed by excitement over the company's $5.2...
SHPG: 239.82 (+6.11), NPSP: 45.88 (+0.03)
Shire's (SHPG) CEO Flemming Ornskov on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 12, 4:44PM CST
SHPG: 239.82 (+6.11)
Alaska AG investigating Impax Labs over possible pay-to-delay deals
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 4:33PM CST
IPXL: 39.51 (+0.69), ENDP: 84.01 (+1.12), PFE: 34.64 (-0.23), SHPG: 239.82 (+6.11)
Shire Moves Up On NPS Potential; Q4 Earnings Miss
at Investor's Business Daily - Thu Feb 12, 9:45AM CST
Shares of Shire (SHPG) moved higher early Thursday as the Irish drugmaker's better-than-expected quarterly revenue and upbeat 2015 outlook offset an earnings miss. Reporting before the open, Shire logged fourth-quarter earnings of $2.63 per American...
AGN: 229.49 (+1.87), VRX: 167.00 (-0.50), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17), NPSP: 45.88 (+0.03), ABBV: 58.05 (+1.00)
Shire (SHPG) Highlighted As Momo Momentum Stock
at The Street - Thu Feb 12, 9:24AM CST
Trade-Ideas LLC identified Shire (SHPG) as a momo momentum candidate
SHPG: 239.82 (+6.11)
Shire Q4 CF Ops up big on receipt of $1.635B break-up fee from AbbVie
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 7:19AM CST
SHPG: 239.82 (+6.11)
Shire PLC misses by $0.04, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 6:41AM CST
SHPG: 239.82 (+6.11)
Shire Delivers Record Revenues and Non GAAP Earnings per ADS in 2014, and Enters 2015 With Strongest-Ever Pipeline
PR Newswire Europe - Thu Feb 12, 6:01AM CST
DUBLIN, Ireland, February 12, 2015 /PRNewswire/ --
SHPG: 239.82 (+6.11)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 4:30PM CST
NLSN: 45.59 (+2.02), RTIX: 5.54 (+0.19), AAP: 150.16 (-1.26), JAH: 51.18 (+0.18), LMNS: 10.80 (+0.57), THS: 80.00 (-1.57), RWLK: 17.40 (-0.77), CAB: 53.55 (+1.23), FAF: 37.00 (+0.10), HSP: 87.35 (unch), PNK: 25.64 (-0.35), MFA: 7.89 (unch), SPW: 87.37 (-2.81), MFC: 17.31 (+0.27), HIMX: 8.04 (+0.28), LNCE: 30.72 (-0.25), TIME: 24.84 (+0.35), AVP: 9.08 (+0.39), INCY: 75.94 (+0.28), NNN: 41.00 (+0.20), NWE: 53.61 (-0.85), COR: 48.08 (+1.08), MHFI: 102.19 (unch), NCI: 14.99 (-0.01), BWA: 60.17 (-1.21), HERO: 0.92 (+0.02), NRP: 7.86 (-0.45), STC: 37.85 (+0.23), AB: 27.17 (+0.47), CPLA: 65.23 (-1.37), TU: 34.83 (+0.01), IFF: 116.96 (+2.19), GNC: 48.11 (-0.55), MINI: 40.62 (-0.83), ACOR: 36.14 (-0.51), CVE: 19.42 (-0.29), SNI: 73.00 (+0.39), CCE: 43.69 (-0.66), K: 63.20 (-0.10), DPS: 76.95 (-1.35), BG: 82.22 (+1.78), AAWW: 48.01 (+0.44), Q: 63.31 (+0.06), SHPG: 239.82 (+6.11), MANU: 17.20 (-0.21), MPEL: 27.54 (+0.78), APA: 67.05 (+2.47), DBD: 35.82 (+1.07), MPW: 14.64 (+0.14), HE: 33.14 (-0.22), RYN: 28.02 (-1.15), CS: 23.65 (+0.23), PDS: 6.04 (+0.12), ANR: 1.27 (+0.03), SON: 46.65 (-0.79), SKYW: 13.84 (+1.88), LPNT: 69.04 (-0.06), RDN: 16.10 (-0.43), MDWD: 7.22 (+0.17), SCOR: 53.35 (-1.10), FLO: 21.68 (+0.38)
Greece Weighs On Stocks; TripAdvisor Up After Close
at Investor's Business Daily - Wed Feb 11, 3:57PM CST
Stocks ended mixed Wednesday as investors awaited the outcome of talks aimed at resolving Greece's debt crisis. The Nasdaq edged up 0.3%, while the S&P 500 ended flat and the Dow Jones industrial average dipped a fraction. Volume was also mixed,...
DPS: 76.95 (-1.35), WWAV: 38.65 (+0.61), WFM: 56.15 (-0.15), TSLA: 203.77 (+0.89), SSNC: 63.38 (+1.40), SHPG: 239.82 (+6.11), AMAT: 24.12 (-0.02), TRIP: 84.81 (+2.41), CSCO: 29.43 (-0.03)
Why Sangamo Biosciences Inc. Shares Rocketed Higher Today
Todd Campbell, The Motley Fool - Motley Fool - Wed Feb 11, 11:58AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Sangamo Biosciences shares surged more than 14%...
BIIB: 391.66 (-0.45), SHPG: 239.82 (+6.11), SGMO: 15.40 (+0.14)
Congratulations Covidien: You Escaped In Time
Chris DeMuth Jr. - Seeking Alpha - Wed Feb 11, 8:19AM CST
Originally published on February 4, 2015 The Shakedown In 2014, Obama vowed to punish tax inverting companies by any means necessary - inside and outside of legislation. He took scalps including Shire (NASDAQ: SHPG ) and Walgreens (NASDAQ: WBA...
VRX: 167.00 (-0.50), WBA: 78.73 (-1.23), MDT: 75.26 (+0.33), COV: 106.71 (-1.36), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17), NPSP: 45.88 (+0.03), ABBV: 58.05 (+1.00)
Will Sangamo (SGMO) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 12:10PM CST
Sangamo BioSciences, Inc. (SGMO) is scheduled to report fourth-quarter 2014 results on Feb 10, 2015 and holds a Zacks Rank #3 (Hold) with an Earnings ESP of 0.00%.
BIIB: 391.66 (-0.45), ACT: 285.37 (+3.71), SHPG: 239.82 (+6.11), SGMO: 15.40 (+0.14)
